title: A phase II study of radiotherapy and concurrent paclitaxel chemotherapy in breast-conserving treatment for node-positive breast cancer.
authors.affiliation: Department of Radiation Oncology, University Hospitals Case Medical Center, Cleveland, OH 44106, USA. janice.lyons@uhhospitals.org
authors.forename: William C
authors.initials: WC
authors.lastname: Chen
authors.forename: Janice
authors.initials: J
authors.lastname: Kim
authors.forename: Edward
authors.initials: E
authors.lastname: Kim
authors.forename: Paula
authors.initials: P
authors.lastname: Silverman
authors.forename: Beth
authors.initials: B
authors.lastname: Overmoyer
authors.forename: Brenda W
authors.initials: BW
authors.lastname: Cooper
authors.forename: Sue
authors.initials: S
authors.lastname: Anthony
authors.forename: Robert
authors.initials: R
authors.lastname: Shenk
authors.forename: Rosemary
authors.initials: R
authors.lastname: Leeming
authors.forename: Shelli H
authors.initials: SH
authors.lastname: Hanks
authors.forename: Janice A
authors.initials: JA
authors.lastname: Lyons
mesh_terms: D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001940:Breast / Q000528:radiation effects; D001943:Breast Neoplasms / Q000401:mortality / Q000473:pathology / Q000628:therapy*; D002248:Carbon Monoxide / Q000378:metabolism; D059248:Chemoradiotherapy / Q000379:methods*; D003520:Cyclophosphamide / Q000008:administration & dosage; D018572:Disease-Free Survival; D019583:Dose Fractionation, Radiation; D004317:Doxorubicin / Q000008:administration & dosage; D004334:Drug Administration Schedule; D005240:Feasibility Studies; D005260:Female; D006801:Humans; D015182:Lymphatic Irradiation; D015412:Mastectomy, Segmental; D008875:Middle Aged; D009367:Neoplasm Staging; D017239:Paclitaxel / Q000008:administration & dosage; D011653:Pulmonary Diffusing Capacity; D011855:Radiodermatitis / Q000209:etiology
chemical_list: D002248:Carbon Monoxide; D004317:Doxorubicin; D003520:Cyclophosphamide; D017239:Paclitaxel